October 31, 2018
SAN DIEGOT Allele Biotechnology & Pharmaceuticals Inc. has received issuance notices from the U.S. Patent and Trademark Office for its first batch of patents covering the derivation of induced pluripotent stem cells (iPSCs). Allele’s proprietary technology uses only messenger RNA (mRNA) to reprogram human or other primate cells, avoiding many operational complications that other methods [...]
October 31, 2018
Agilent OnePGT solution empowers fertility specialists to attain comprehensive insights to improve the ranking of in vitro fertilized (IVF) embryos SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution for preimplantation genetic testing (PGT). OnePGT allows parallel detection of multiple monogenic disorders (PGT-M), [...]
October 31, 2018
Expands Database for Detection of Sugar Syrups and Verification of Geographical and Botanical Origin SHANGHAI, China - At the Analytica China 2018 (www.analyticachina.com), Bruker today announced the release of its proprietary Honey-Profiling 2.0 method for the NMR FoodScreener® platform, which has been granted ISO/IEC 17025 accreditation already in 2015. The new method was developed in collaboration with partners QSI and [...]
October 31, 2018
COLOGNE, Germany & LEIDEN, Netherlands & CAMBRIDGE, England--Ncardia, a leader in human iPSC-based solutions for drug safety and efficacy screening, and Horizon Discovery Group plc (LSE:HZD) (Horizon), a global leader in gene editing and gene modulation technologies, announced a partnership to provide custom genetically modified and differentiated human iPSC-derived cells (hiPSC) for drug discovery researchers. [...]
Consistent High Quality Cell Line Controls
October 30, 2018
AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications. Variations in FFPE tissue sample quality and experimental setup can lead to misleading results without reliable controls. Traditional cell or tissue-based control specimens often present intra specimen variation, lot-to-lot variations [...]
Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling
October 30, 2018
SAN DIEGO-- Illumina, Inc. (NASDAQ: ILMN) today announces the launch of TruSightTM Oncology 500 (TSO 500), a comprehensive pan-cancer assay designed to identify known and emerging tumor biomarkers. TruSight Oncology 500 utilizes both DNA and RNA from subject tumor samples to identify key somatic variants underlying tumor progression, such as small DNA variants, fusions, and splice variants. Importantly, [...]
Twist Bioscience Corporation Announces Pricing of Initial Public Offering
October 30, 2018
SAN FRANCISCO--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions. All of the shares of common stock are [...]
XCR Diagnostics and Luminex Enter into License Agreement
October 30, 2018
SALT LAKE CITY--Privately held XCR Diagnostics Inc. and Luminex Corporation (Nasdaq:LMNX) have entered into a non-exclusive, worldwide license agreement for XCR's proprietary Xtreme Chain Reaction nucleic acid amplification technology. The XCR technology enables extremely rapid thermal cycling protocols to achieve dramatically reduced assay turnaround times compared to traditional polymerase chain reaction. Financial terms were not disclosed. “XCR [...]
eMolecules strengthens and re-structures its Board through the appointment of two new members
October 30, 2018
SAN DIEGO -- eMolecules is pleased to announce the addition of two new members to the Board of Directors: Manuel Brocke-Benz and Max Carnecchia. The Board, strengthened by the arrival of Max and Manuel, provides strategic leadership for eMolecules. Max and Manuel will bring the experience and strategic focus required to drive eMolecules forward in its vision to simplify the search, find [...]
Rheonix Announces Launch of NGS OnePrep™ Automated DNA Extraction and Library Preparation Solution
October 30, 2018
ITHACA, N.Y.---Rheonix, Inc. announces the launch of its NGS OnePrep™ solution, an integrated, automated method for DNA extraction and next-generation sequencing (NGS) library preparation on the Encompass Optimum™ workstation, at the Association of Molecular Pathology (AMP) Annual Meeting and Expo Nov.1-3 in San Antonio, Texas. The method will allow laboratory technicians to produce sequence-ready libraries [...]

